RxDoctor Payments Data

James Hall, APRN

Family · Hazard, KYNPI 1679888119

Payments from drug & device makers

$489in general payments, 2019–2025

Across 27 payments — averaging $18.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$99
  • AbbVie$61
  • Corcept Therapeutics$54
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$48
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$44
  • Johnson & Johnson$42
  • plus $141 from 5 others

What the payments were for

  • Food & beverage$489100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$489 in reported general payments places this provider in the 50th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$3,184
Medicare patients
81
Services billed
262

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol29$20,821
JanuviaSitagliptin Phosphate19$20,227
OzempicSemaglutide18$19,496
Breztri AerosphereBudesonide/Glycopyr/Formoterol26$18,608
JardianceEmpagliflozin20$16,578
LinzessLinaclotide26$15,999
TradjentaLinagliptin19$9,585
JanumetSitagliptin Phos/Metformin Hcl11$6,004
VascepaIcosapent Ethyl12$4,462
Albuterol Sulfate HfaAlbuterol Sulfate98$2,813
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen103$1,846
Ventolin HfaAlbuterol Sulfate22$1,248
Diclofenac Sodium56$874
Ultra-Fine Nano Pen NeedlePen Needle, Diabetic13$847
Metronidazole15$831

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere$39$39,42955 claims
Boehringer IngelheimJardiance, Tradjenta$40$26,16339 claims
AbbVieLinzess, Synthroid$61$16,73642 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 4,374 family providers in Kentucky.

Other family in Hazard

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →